Wellington Shields & Co’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$96.9K Hold
17,000
0.02% 287
2026
Q1
$65.8K Hold
17,000
0.02% 292
2025
Q4
$71.1K Hold
17,000
0.02% 289
2025
Q3
$55.9K Hold
17,000
0.01% 298
2025
Q2
$24.1K Hold
17,000
0.01% 306
2025
Q1
$25.3K Hold
17,000
0.01% 290
2024
Q4
$19K Hold
17,000
0.01% 286
2024
Q3
$16.1K Hold
17,000
﹤0.01% 302
2024
Q2
$26.9K Hold
17,000
0.01% 290
2024
Q1
$24.6K Hold
17,000
0.01% 292
2023
Q4
$22.8K Hold
17,000
0.01% 284
2023
Q3
$24.1K Hold
17,000
0.01% 278
2023
Q2
$19.6K Hold
17,000
﹤0.01% 280
2023
Q1
$18K Hold
17,000
﹤0.01% 287
2022
Q4
$25.8K Hold
17,000
0.01% 278
2022
Q3
$36K Hold
17,000
0.02% 258
2022
Q2
$23K Hold
17,000
0.01% 271
2022
Q1
$36K Hold
17,000
0.01% 223
2021
Q4
$63K Hold
17,000
0.01% 226
2021
Q3
$85K Hold
17,000
0.03% 207
2021
Q2
$111K Hold
17,000
0.04% 205
2021
Q1
$117K Sell
17,000
-8,600
-34% -$72.7K 0.04% 194
2020
Q4
$261K Hold
25,600
0.09% 151
2020
Q3
$90K Hold
25,600
0.04% 170
2020
Q2
$128K Hold
25,600
0.06% 168
2020
Q1
$87K Hold
25,600
0.05% 149
2019
Q4
$140K Buy
+25,600
New +$144K 0.06% 168
2019
Q3
Sell
-285,800
Closed -$2.19M 177
2019
Q2
$2.19M Sell
285,800
-30,000
-9% -$162K 1.03% 21
2019
Q1
$1.66M Buy
315,800
+144,000
+84% +$998K 0.85% 32
2018
Q4
$1.12M Sell
171,800
-153,800
-47% -$1.72M 0.64% 41
2018
Q3
$5.61M Sell
325,600
-10,000
-3% -$149K 3.04% 3
2018
Q2
$4.68M Buy
335,600
+29,600
+10% +$500K 2.42% 8
2018
Q1
$4.69M Buy
+306,000
New +$4.37M 2.53% 6

Other funds holding PGEN

Wellington Shields & Co's PGEN Position: Q2 2026 in Review

Wellington Shields & Co held its Precigen (PGEN) position steady in Q2 2026 at 17,000 shares worth $96.9K. The position accounts for 0.02% of the portfolio, ranked #287.

Wellington Shields & Co first reported a position in PGEN in Q1 2018 and has held it in 33 quarters since. The position peaked at $5.61M in Q3 2018. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Wellington Shields & Co held 17,000 shares of Precigen worth $96.9K as of Q2 2026.
  • Wellington Shields & Co left its Precigen share count unchanged in Q2 2026.
  • Precigen made up 0.02% of Wellington Shields & Co's portfolio in Q2 2026, its #287 holding.
  • Wellington Shields & Co first reported a position in Precigen in Q1 2018 and has held it in 33 quarters since.
  • Wellington Shields & Co's Precigen position peaked at $5.61M in Q3 2018.
  • 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Wellington Shields & Co's 13F filing for Q2 2026, filed 10 Aug 2026.